- 如果營收成長率小於推銷費用成長率, 可能代表產品需要很多的促銷才能賣掉, 或是產品有問題需要花額外的推銷成本來善後
- 發展品牌的公司不樂見推銷費用率的下滑, 對此類型公司推銷費用率等同於走技術類型公司的研發費用率
營收淨額 QoQ YoY | 推銷費用 QoQ YoY | 管理費用 QoQ YoY | 研發費 QoQ YoY | 推銷費用率(%) QoQ YoY | 管理費用率(%) QoQ YoY | 研發費用率(%) QoQ YoY | 員工人數 QoQ YoY | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
24Q3 (20) | 19.48 | -12.09 | -1.72 | 1.14 | -1.72 | -0.87 | 0.44 | -24.14 | -13.73 | 0.32 | 3.23 | 18.52 | 5.85 | 11.8 | 0.86 | 2.26 | -13.7 | -12.22 | 1.64 | 17.43 | 20.59 | 0 | 0 | 0 |
24Q2 (19) | 22.16 | 6.08 | -2.51 | 1.16 | 14.85 | 16.0 | 0.58 | 11.54 | 31.82 | 0.31 | 3.33 | -3.12 | 5.23 | 8.27 | 18.98 | 2.62 | 5.15 | 35.21 | 1.40 | -2.59 | -0.63 | 0 | 0 | 0 |
24Q1 (18) | 20.89 | -38.01 | 12.43 | 1.01 | -16.53 | 31.17 | 0.52 | -1.89 | 20.93 | 0.3 | -14.29 | 0.0 | 4.83 | 34.66 | 16.66 | 2.49 | 58.28 | 7.56 | 1.44 | 38.28 | -11.06 | 0 | 0 | 0 |
23Q4 (17) | 33.7 | 70.03 | 37.27 | 1.21 | 5.22 | -23.9 | 0.53 | 3.92 | -18.46 | 0.35 | 29.63 | 0.0 | 3.59 | -38.12 | -44.56 | 1.57 | -38.88 | -40.6 | 1.04 | -23.76 | -27.15 | 0 | 0 | 0 |
23Q3 (16) | 19.82 | -12.8 | 10.85 | 1.15 | 15.0 | -9.45 | 0.51 | 15.91 | 15.91 | 0.27 | -15.62 | -15.62 | 5.80 | 31.88 | -18.31 | 2.57 | 32.93 | 4.56 | 1.36 | -3.24 | -23.88 | 0 | 0 | 0 |
23Q2 (15) | 22.73 | 22.34 | 15.21 | 1.0 | 29.87 | 28.21 | 0.44 | 2.33 | -8.33 | 0.32 | 6.67 | 14.29 | 4.40 | 6.16 | 11.28 | 1.94 | -16.36 | -20.43 | 1.41 | -12.81 | -0.8 | 0 | 0 | 0 |
23Q1 (14) | 18.58 | -24.32 | 24.36 | 0.77 | -51.57 | -14.44 | 0.43 | -33.85 | -2.27 | 0.3 | -14.29 | 0.0 | 4.14 | -36.01 | -31.21 | 2.31 | -12.59 | -21.42 | 1.61 | 13.26 | -19.59 | 0 | 0 | 0 |
22Q4 (13) | 24.55 | 37.3 | 47.8 | 1.59 | 25.2 | 63.92 | 0.65 | 47.73 | 47.73 | 0.35 | 9.38 | 16.67 | 6.48 | -8.82 | 10.9 | 2.65 | 7.59 | -0.05 | 1.43 | -20.34 | -21.07 | 0 | 0 | 0 |
22Q3 (12) | 17.88 | -9.38 | 26.9 | 1.27 | 62.82 | 56.79 | 0.44 | -8.33 | 37.5 | 0.32 | 14.29 | 23.08 | 7.10 | 79.67 | 23.56 | 2.46 | 1.15 | 8.35 | 1.79 | 26.11 | -3.01 | 0 | 0 | 0 |
22Q2 (11) | 19.73 | 32.06 | 44.01 | 0.78 | -13.33 | -14.29 | 0.48 | 9.09 | 9.09 | 0.28 | -6.67 | 16.67 | 3.95 | -34.37 | -40.48 | 2.43 | -17.39 | -24.25 | 1.42 | -29.33 | -18.99 | 0 | 0 | 0 |
22Q1 (10) | 14.94 | -10.05 | 20.29 | 0.9 | -7.22 | 34.33 | 0.44 | 0.0 | 18.92 | 0.3 | 0.0 | 50.0 | 6.02 | 3.15 | 11.67 | 2.95 | 11.18 | -1.14 | 2.01 | 11.18 | 24.7 | 0 | 0 | 0 |
21Q4 (9) | 16.61 | 17.89 | 15.91 | 0.97 | 19.75 | 8.99 | 0.44 | 37.5 | 2.33 | 0.3 | 15.38 | 20.0 | 5.84 | 1.58 | -5.97 | 2.65 | 16.64 | -11.72 | 1.81 | -2.12 | 3.53 | 0 | 0 | 0 |
21Q3 (8) | 14.09 | 2.85 | 17.61 | 0.81 | -10.99 | 30.65 | 0.32 | -27.27 | -11.11 | 0.26 | 8.33 | 8.33 | 5.75 | -13.45 | 11.08 | 2.27 | -29.29 | -24.42 | 1.85 | 5.33 | -7.89 | 0 | 0 | 0 |
21Q2 (7) | 13.7 | 10.31 | 7.79 | 0.91 | 35.82 | 42.19 | 0.44 | 18.92 | 33.33 | 0.24 | 20.0 | -29.41 | 6.64 | 23.13 | 31.91 | 3.21 | 7.81 | 23.7 | 1.75 | 8.79 | -34.51 | 0 | 0 | 0 |
21Q1 (6) | 12.42 | -13.33 | 2.48 | 0.67 | -24.72 | 1.52 | 0.37 | -13.95 | 5.71 | 0.2 | -20.0 | -28.57 | 5.39 | -13.14 | -0.94 | 2.98 | -0.72 | 3.16 | 1.61 | -7.7 | -30.3 | 0 | 0 | 0 |
20Q4 (5) | 14.33 | 19.62 | 5.29 | 0.89 | 43.55 | 14.1 | 0.43 | 19.44 | 2.38 | 0.25 | 4.17 | -16.67 | 6.21 | 20.01 | 8.37 | 3.00 | -0.14 | -2.76 | 1.74 | -12.92 | -20.85 | 0 | 0 | 0 |
20Q3 (4) | 11.98 | -5.74 | 0.0 | 0.62 | -3.12 | 0.0 | 0.36 | 9.09 | 0.0 | 0.24 | -29.41 | 0.0 | 5.18 | 2.78 | 0.0 | 3.01 | 15.74 | 0.0 | 2.00 | -25.11 | 0.0 | 0 | 0 | 0.0 |
20Q2 (3) | 12.71 | 4.87 | 0.0 | 0.64 | -3.03 | 0.0 | 0.33 | -5.71 | 0.0 | 0.34 | 21.43 | 0.0 | 5.04 | -7.53 | 0.0 | 2.60 | -10.09 | 0.0 | 2.68 | 15.79 | 0.0 | 0 | 0 | 0.0 |
20Q1 (2) | 12.12 | -10.95 | 0.0 | 0.66 | -15.38 | 0.0 | 0.35 | -16.67 | 0.0 | 0.28 | -6.67 | 0.0 | 5.45 | -4.98 | 0.0 | 2.89 | -6.42 | 0.0 | 2.31 | 4.81 | 0.0 | 0 | 0 | 0.0 |
19Q4 (1) | 13.61 | 0.0 | 0.0 | 0.78 | 0.0 | 0.0 | 0.42 | 0.0 | 0.0 | 0.3 | 0.0 | 0.0 | 5.73 | 0.0 | 0.0 | 3.09 | 0.0 | 0.0 | 2.20 | 0.0 | 0.0 | 0 | 0.0 | 0.0 |
營收淨額 YoY | 推銷費用 YoY | 管理費用 YoY | 研發費 YoY | 推銷費用率(%) YoY | 管理費用率(%) YoY | 研發費用率(%) YoY | 員工人數 YoY | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2023 (10) | 94.83 | 23.01 | 4.13 | -9.03 | 1.91 | -5.45 | 1.24 | -0.8 | 4.36 | -26.05 | 2.01 | -23.13 | 1.31 | -19.36 | 0 | 0 |
2022 (9) | 77.09 | 35.67 | 4.54 | 35.12 | 2.02 | 28.66 | 1.25 | 25.0 | 5.89 | -0.41 | 2.62 | -5.17 | 1.62 | -7.87 | 0 | 0 |
2021 (8) | 56.82 | 11.11 | 3.36 | 19.57 | 1.57 | 6.8 | 1.0 | -9.91 | 5.91 | 7.62 | 2.76 | -3.87 | 1.76 | -18.92 | 0 | 0 |
2020 (7) | 51.14 | 6.12 | 2.81 | 8.08 | 1.47 | 2.08 | 1.11 | 2.78 | 5.49 | 1.84 | 2.87 | -3.81 | 2.17 | -3.15 | 0 | 0 |
2019 (6) | 48.19 | 12.7 | 2.6 | 9.24 | 1.44 | 0.0 | 1.08 | 8.0 | 5.40 | -3.07 | 2.99 | -11.27 | 2.24 | -4.17 | 0 | 0 |
2018 (5) | 42.76 | 13.0 | 2.38 | 17.82 | 1.44 | 2.13 | 1.0 | 4.17 | 5.57 | 4.27 | 3.37 | -9.62 | 2.34 | -7.82 | 0 | 0 |
2017 (4) | 37.84 | -3.12 | 2.02 | -0.49 | 1.41 | 6.82 | 0.96 | 7.87 | 5.34 | 2.72 | 3.73 | 10.26 | 2.54 | 11.34 | 0 | 0 |
2016 (3) | 39.06 | 10.25 | 2.03 | 18.71 | 1.32 | 3.94 | 0.89 | 3.49 | 5.20 | 7.68 | 3.38 | -5.72 | 2.28 | -6.13 | 606 | 0.0 |
2015 (2) | 35.43 | 4.11 | 1.71 | -1.16 | 1.27 | 1.6 | 0.86 | -14.0 | 4.83 | -5.06 | 3.58 | -2.41 | 2.43 | -17.4 | 606 | 0.0 |
2014 (1) | 34.03 | -1.56 | 1.73 | 7.45 | 1.25 | -2.34 | 1.0 | 20.48 | 5.08 | 0 | 3.67 | 0 | 2.94 | 0 | 606 | 0.0 |